Massey C, Dharmarajan A, Bannuru RR, Rebeiz E (2019) Management of N0 neck in early oral squamous cell carcinoma: a systematic review and meta-analysis. Laryngoscope 129:E284–E298. https://doi.org/10.1002/lary.27627
Sharbel DD, Abkemeier M, Groves MW, Albergotti WG, Byrd JK, Reyes-Gelves C (2021) Occult metastasis in laryngeal squamous cell carcinoma: a systematic review and meta-analysis. Ann Otol Rhinol Laryngol 130:67–77. https://doi.org/10.1177/0003489420937744
Petruzzelli GJ (2000) The biology of tumor invasion, angiogenesis and lymph node metastasis. ORL J Otorhinolaryngol Relat Spec 62:178–185. https://doi.org/10.1159/000027744
Article PubMed CAS Google Scholar
Asgari Y, Zabihinpour Z, Salehzadeh-Yazdi A, Schreiber F, Masoudi-Nejad A (2015) Alterations in cancer cell metabolism: the Warburg effect and metabolic adaptation. Genomics 105:275–281. https://doi.org/10.1016/j.ygeno.2015.03.001
Article PubMed CAS Google Scholar
Halestrap AP (2012) The monocarboxylate transporter family–Structure and functional characterization. IUBMB Life 64:1–9. https://doi.org/10.1002/iub.573
Article PubMed CAS Google Scholar
Bosshart PD, Charles RP, Garibsingh RA, Schlessinger A, Fotiadis D (2021) SLC16 Family: from atomic structure to human disease. Trends Biochem Sci 46:28–40. https://doi.org/10.1016/j.tibs.2020.07.005
Article PubMed CAS Google Scholar
Perri F, Della Vittoria Scarpati G, Pontone M, Marciano ML, Ottaiano A, Cascella M, Sabbatino F, Guida A, Santorsola M, Maiolino P, Cavalcanti E, Togo G, Ionna F, Caponigro F (2022) Cancer cell metabolism reprogramming and its potential implications on therapy in squamous cell carcinoma of the head and neck: a review. Cancers (Basel) 14:3560. https://doi.org/10.3390/cancers14153560
Article PubMed CAS Google Scholar
Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW, Mueller-Klieser W (2001) Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 51:349–353. https://doi.org/10.1016/s0360-3016(01)01630-3
Article PubMed CAS Google Scholar
Pinheiro C, Longatto-Filho A, Azevedo-Silva J, Casal M, Schmitt FC, Baltazar F (2012) Role of monocarboxylate transporters in human cancers: state of the art. J Bioenerg Biomembr 44:127–139. https://doi.org/10.1007/s10863-012-9428-1
Article PubMed CAS Google Scholar
Pertega-Gomes N, Vizcaino JR, Felisbino S, Warren AY, Shaw G, Kay J, Whitaker H, Lynch AG, Fryer L, Neal DE, Massie CE (2015) Epigenetic and oncogenic regulation of SLC16A7 MCT2 results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer. Oncotarget 6:21675–21684. https://doi.org/10.18632/oncotarget.4328
Article PubMed PubMed Central Google Scholar
Khalyfa A, Qiao Z, Raju M, Shyu CR, Coghill L, Ericsson A, Gozal D (2021) Monocarboxylate transporter-2 expression restricts tumor growth in a murine model of lung cancer: a multi-omic analysis. Int J Mol Sci 22:10616. https://doi.org/10.3390/ijms221910616
Article PubMed PubMed Central CAS Google Scholar
Zhu J, Wu YN, Zhang W, Zhang XM, Ding X, Li HQ, Geng M, Xie ZQ, Wu HM (2014) Monocarboxylate transporter 4 facilitates cell proliferation and migration and is associated with poor prognosis in oral squamous cell carcinoma patients. PLoS ONE 9:e87904. https://doi.org/10.1371/journal.pone.0087904
Article PubMed PubMed Central CAS Google Scholar
Simões-Sousa S, Granja S, Pinheiro C, Fernandes D, Longatto-Filho A, Laus AC, Alves CD, Suárez-Peñaranda JM, Pérez-Sayáns M, Lopes Carvalho A, Schmitt FC, García-García A, Baltazar, (2016) Prognostic significance of monocarboxylate transporter expression in oral cavity tumors. Cell Cycle 15:1865–1873. https://doi.org/10.1080/15384101.2016.1188239
Article PubMed PubMed Central CAS Google Scholar
Ding Z, Xiao T, Huang J, Yuan Y, Ye Q, Xuan M, Xie H, Wang X (2019) Elective neck dissection versus observation in squamous cell carcinoma of oral cavity with clinically n0 neck: a systematic review and meta-analysis of prospective studies. J Oral Maxillofac Surg 77:184–194. https://doi.org/10.1016/j.joms.2018.08.007
Franchi A, Gallo O, Boddi V, Santucci M (1996) Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination. Clin Cancer Res 2:1801–1808
Capaccio P, Pruneri G, Carboni N, Pagliari AV, Quatela M, Cesana BM, Pignataro L (2000) Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes. Head Neck 22:234–240. https://doi.org/10.1002/(sici)1097-0347(200005)22:3%3c234:aid-hed5%3e3.0.co;2-3
Article PubMed CAS Google Scholar
Myo K, Uzawa N, Miyamoto R, Sonoda I, Yuki Y, Amagasa T (2005) Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM stage I and II squamous cell carcinoma of the oral cavity. Cancer 104:2709–2716. https://doi.org/10.1002/cncr.21491
Article PubMed CAS Google Scholar
Huber GF, Züllig L, Soltermann A, Roessle M, Graf N, Haerle SK, Studer G, Jochum W, Moch H, Stoeckli SJ (2011) Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx. BMC Cancer 11(217):1–8. https://doi.org/10.1186/1471-2407-11-217
Züllig L, Roessle M, Weber C, Graf N, Haerle SK, Jochum W, Stoeckli SJ, Moch H, Huber GF (2013) High sex determining region Y-box 2 expression is a negative predictor of occult lymph node metastasis in early squamous cell carcinomas of the oral cavity. Eur J Cancer 49:1915–1922. https://doi.org/10.1016/j.ejca.2013.01.005
Article PubMed CAS Google Scholar
Kelner N, Rodrigues PC, Bufalino A, Fonseca FP, Santos-Silva AR, Miguel MC, Pinto CA, Leme AF, Graner E, Salo T, Kowalski LP, Coletta RD (2015) Activin a immunoexpression as predictor of occult lymph node metastasis and overall survival in oral tongue squamous cell carcinoma. Head Neck 37:479–486. https://doi.org/10.1002/hed.23627
Noorlag R, Boeve K, Witjes MJ, Koole R, Peeters TL, Schuuring E, Willems SM, van Es RJ (2017) Amplification and protein overexpression of cyclin D1: predictor of occult nodal metastasis in early oral cancer. Head Neck 39:326–333. https://doi.org/10.1002/hed.24584
Mermod M, Bongiovanni M, Petrova TV, Dubikovskaya EA, Simon C, Tolstonog G, Monnier Y (2016) Prediction of occult lymph node metastasis in squamous cell carcinoma of the oral cavity and the oropharynx using peritumoral prospero homeobox protein 1 lymphatic nuclear quantification. Head Neck 38:1407–1415. https://doi.org/10.1002/hed.24452
Mermod M, Bongiovanni M, Petrova T, Goun E, Simon C, Tolstonog G, Monnier Y (2019) Prediction of occult lymph node metastasis in head and neck cancer with CD31 vessel quantification. Otolaryngol Head Neck Surg 160:277–283. https://doi.org/10.1177/0194599818791779
Boeve K, Mastik MF, Slagter-Menkema L, van Dijk BAC, Roodenburg JLN, van der Laan BFAM, Witjes MJH, van der Vegt B, Schuuring E (2021) Cortactin expression assessment improves patient selection for a watchful waiting strategy in pT1cN0-staged oral squamous cell carcinomas with a tumor infiltration depth below 4 mm. Head Neck 43:2688–2697. https://doi.org/10.1002/hed.26746
Article PubMed PubMed Central Google Scholar
Meler-Claramonte C, Avilés-Jurado FX, Vilaseca I, Terra X, Bragado P, Fuster G, León Vintró X, Camacho M (2022) Semaphorin-3F/neuropilin-2 transcriptional expression as a predictive biomarker of occult lymph node metastases in HNSCC. Cancers 14:2259. https://doi.org/10.3390/cancers14092259
Article PubMed PubMed Central CAS Google Scholar
.-Califf RM, (2018) Biomarker definitions and their applications. Exp Biol Med (Maywood) 243:213–221. https://doi.org/10.1177/1535370217750088
Article PubMed CAS Google Scholar
Economopoulou P, de Bree R, Kotsantis I, Psyrri A (2019) Diagnostic tumor markers in head and neck squamous cell carcinoma (HNSCC) in the clinical setting. Front Oncol 9:827. https://doi.org/10.
Comments (0)